In Vitro Hemolysis Evaluation of the Second Heart Assist Whisper Percutaneous Mechanical Circulatory Support Device
Artificial Organs · 2025-07 · 49 (7) · 1119-1125
DOI: 10.1111/aor.14979 ↗Kurz gefasst
Fachartikel in der Zeitschrift Artificial Organs, online erschienen am 24.02.2025. Verfasst von Chris H H Chan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Innovative Device and Engineering Applications Lab, The Texas Heart Institute, Houston, Texas, USA. Hauptthemen laut MEDLINE: Hemolysis, Heart-Assist Devices. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: Second Heart Assist Inc.
Abstract (Originalsprache)
Background
High rotational pump speeds in percutaneous mechanical circulatory support (pMCS) devices frequently result in hemolysis. Consequently, in vitro hemolysis testing for newly developed devices is essential to mitigate this significant risk. This study compared the degree of hemolysis induced by the Second Heart Assist Whisper pMCS at its maximum pump speed, representing the worst‐case scenario, with that of the Impella CP, following American society for testing and materials standards.
Methods
Five Whisper devices were tested at 10000 RPM, while a comparator Impella CP was operated at 44 133 ± 606 RPM to match the Whisper's flow rate. Both devices were evaluated in two identical in vitro blood circulatory loops using citrated bovine blood. Hemolysis was analyzed by the tetramethylbenzidine method.
Results
The change in plasma free hemoglobin (Δ pf Hb) was significantly greater with the Impella CP than with the Whisper ( p < 0.01). Both devices caused a steady increase in pf Hb, with significant differences after 60 min of in vitro testing ( p < 0.01). The Whisper and Impella CP differed significantly in normalized index of hemolysis (0.088 ± 0.022 vs. 0.194 ± 0.029 g/100, p < 0.01) and modified index of hemolysis (9.72 ± 2.4 vs. 20.83 ± 3.5, p < 0.01).
Conclusion
The Whisper exhibited superior hemolytic performance to that of the Impella CP under identical hemodynamic conditions. Our newly designed blood circulatory loop and these benchmark values will aid future in vitro hemolysis testing for pMCS devices.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Innovative Device and Engineering Applications Lab, The Texas Heart Institute, Houston, Texas, USA.
- Interventional Cardiology, the Texas Heart Institute Center for Cardiovascular Care, The Texas Heart Institute, Houston, Texas, USA.
- Second Heart Assist, Salt Lake City, Utah, USA.
ORCID-Profile: Chris H H Chan, Asma Farooqui
Förderung
- Second Heart Assist Inc
Zitieren
APA
Chan, C. H. H., Farooqui, A., Peak, P., Wang, Y., Kode, S., Al-Sahli, H., Krajcer, Z., Chaudhari, S., Richardson, A., & Miller, L. (2025). In Vitro Hemolysis Evaluation of the Second Heart Assist Whisper Percutaneous Mechanical Circulatory Support Device. Artificial Organs, 49(7), 1119-1125. https://doi.org/10.1111/aor.14979
Vancouver
Chan CHH, Farooqui A, Peak P, Wang Y, Kode S, Al-Sahli H, et al. In Vitro Hemolysis Evaluation of the Second Heart Assist Whisper Percutaneous Mechanical Circulatory Support Device. Artificial Organs. 2025;49(7):1119-1125. doi:10.1111/aor.14979
BibTeX
@article{Chan2025,
author = {Chan, Chris H H and Farooqui, Asma and Peak, Preston and Wang, Yaxin and Kode, Sai and Al-Sahli, Hadeel and Krajcer, Zvonimir and Chaudhari, Sejal and Richardson, Alex and Miller, Leslie},
title = {In Vitro Hemolysis Evaluation of the Second Heart Assist Whisper Percutaneous Mechanical Circulatory Support Device},
journal = {Artificial Organs},
year = {2025},
volume = {49},
number = {7},
pages = {1119--1125},
doi = {10.1111/aor.14979}
}
EUVIMED